This is a StreetInsider.com Premium Only Page

(STRO) – StreetInsider.com Reports

Apr 3, 2024 02:01 PM Oppenheimer Reiterates Outperform Rating on Sutro Biopharma (STRO)

Apr 3, 2024 06:48 AM Sutro Biopharma (STRO) PT Lowered to $11 at Piper Sandler

Apr 2, 2024 04:12 PM Sutro Biopharma (STRO) PT Lowered to $18 at Truist Securities

Apr 2, 2024 06:21 AM Sutro Biopharma Inc. (STRO) Prices 14.48M Share Offering at $5.18/sh

Mar 26, 2024 08:09 AM Sutro Biopharma (STRO) PT Lowered to $8 at Wedbush

Mar 26, 2024 06:07 AM Sutro Biopharma (STRO) PT Lowered to $12 at H.C. Wainwright on STRO-001 discontinuation

Mar 26, 2024 03:01 AM Sutro Biopharma, Inc. (STRO) Reports FY Loss of $1.78

Dec 11, 2023 04:05 PM Sutro Biopharma Inc. (STRO) Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin

Nov 30, 2023 07:45 AM Sutro Biopharma (STRO) Trades Higher in Sympathy with Immunogen (IMGN)

Nov 27, 2023 04:00 PM Vaxcyte (PCVX) Exercises Option to Enter Manufacturing Rights Agreement with Sutro Biopharma (STRO) for Cell-Free Extract for its Vaccine Candidates

Nov 21, 2023 04:07 PM Sutro Biopharma (STRO) Appoints Jane Chung to President and COO

Nov 15, 2023 06:43 AM Sutro Biopharma (STRO) PT Lowered to $12 at Piper Sandler

Nov 13, 2023 05:46 PM Sutro Biopharma, Inc. (STRO) Misses Q3 EPS by 7c

Nov 13, 2023 05:21 PM Sutro Biopharma Inc. (STRO) Files $300M Mixed Shelf

Nov 8, 2023 04:17 PM Deutsche Bank Starts Sutro Biopharma (STRO) at Buy, 'favorable risk/reward'

Oct 5, 2023 05:36 PM After-hours movers: Levi falls following EPS, AMC gains on Taylor Switt sales

Oct 5, 2023 04:27 PM Oppenheimer Starts Sutro Biopharma (STRO) at Outperform; sees ~200% upside

Sep 19, 2023 08:03 AM Sutro Biopharma Inc. (STRO) names Hans-Peter Gerber as Chief Scientific Officer

Aug 11, 2023 05:31 AM Sutro Biopharma, Inc. (STRO) Tops Q2 EPS by 9c

Apr 27, 2023 04:30 PM Sutro Biopharma Inc. (STRO) Announces Departure of President of Research & Chief Scientific Officer

Apr 3, 2023 03:11 AM Sutro Biopharma (STRO) PT Lowered to $17 at JMP Securities

Mar 31, 2023 06:36 AM Sutro Biopharma (STRO) PT Lowered to $16 at H.C. Wainwright

Mar 20, 2023 04:29 PM Wells Fargo Assumes Sutro Biopharma (STRO) at Equal Weight

Feb 28, 2023 08:01 AM Sutro Biopharma (STRO) Appoints Anne Borgman as Chief Medical Officer

Jan 13, 2023 07:35 AM Sutro Biopharma (STRO) PT Raised to $25 at Truist Securities

Jan 10, 2023 06:18 AM Sutro Biopharma (STRO) PT Raised to $18 at Piper Sandler

Jan 9, 2023 04:05 PM Sutro Biopharma (STRO) Reports Updates from STRO-002 Phase 1 Trial

Nov 9, 2022 07:15 AM Sutro Biopharma (STRO) PT Lowered to $20 at H.C. Wainwright

Oct 24, 2022 07:01 AM Sutro Biopharma Inc. (STRO) Announces Chief Medical Officer Departure

Aug 23, 2022 06:03 AM Sutro Biopharma (STRO) PT Lowered to $21 at Truist Securities

Aug 18, 2022 06:17 AM Sutro Biopharma (STRO) PT Lowered to $15 at Wells Fargo

Aug 9, 2022 09:35 AM Sutro Biopharma (STRO) PT Lowered to $26 at Berenberg

Jul 26, 2022 04:04 PM Sutro Biopharma Inc. (STRO) Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck

Jun 28, 2022 02:10 PM Sutro Biopharma (STRO) PT Raised to $16 at Piper Sandler

Jun 28, 2022 09:11 AM Pre-Open Stock Movers 06/28: Spirit Gains on Revised Bid; Nike Falls Following Results (more...)

Jun 28, 2022 07:21 AM Sutro Biopharma Inc. (STRO) Climbs 23% Following Pact with Astellas

Jun 28, 2022 05:45 AM Sutro Biopharma (STRO) and Astellas Enter Global Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)

May 23, 2022 06:19 AM Sutro Biopharma (STRO) PT Lowered to $14 at Piper Sandler

Jan 6, 2022 09:25 AM Pre-Open Stock Movers 01/06: (MGTA) (SLGC) (BBBY) Higher; (BLI) (STRO) (WU) Lower (more...)

Jan 5, 2022 05:48 PM After-Hours Stock Movers 01/05: (SLGC) (MGTA) (BNTX) Higher; (BLI) (STRO) (HEAR) Lower (more...)

Jan 5, 2022 04:32 PM Sutro Biopharma Inc. (STRO) Reports Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer

Dec 27, 2021 07:02 AM Sutro Biopharma Inc. (STRO) and Tasly Biopharmaceuticals Announce Exclusive License Agreement for STRO-002 in Greater China

Nov 17, 2021 07:02 AM Sutro Biopharma Inc. (STRO) Appoints Heidi Hunter to its Board

Oct 12, 2021 07:02 AM Sutro Biopharma Inc. (STRO) Announces Collaboration with BioNova Pharmaceuticals for STRO-001 in Greater China

Oct 1, 2021 07:33 AM Sutro Biopharma (STRO) TIVDAK Management Meeting Thoughts - Wells Fargo

Sep 30, 2021 07:01 AM Sutro Biopharma (STRO) Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck

Aug 18, 2021 07:01 AM Sutro Biopharma (STRO) Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer

Jun 18, 2021 06:33 AM UPDATE: H.C. Wainwright Starts Sutro Biopharma (STRO) at Buy

Mar 19, 2021 01:54 AM Sutro Biopharma (STRO) PT Raised to $28 at JMP Securities

Jan 28, 2021 07:05 AM Sutro Biopharma (STRO) PT Raised to $37 at Truist Securities